Plus: One of Elon Musk’s old enemies joins the race to run General Motors. And the third “Avatar” movie opens to about $345 million worldwide, well below the second film’s $435 million. Daniel Bach hosts.
A.M. Edition for Dec. 22. Congress breaks for the holidays without renewing enhanced ACA subsidies. The WSJ’s Sabrina Sidiqui explains what could break the impasse, as millions face higher healthcare premiums and lingering uncertainty. Plus, after seizing a second tanker over the weekend, the U.S. Coast Guard hunts another ship involved in moving Venezuelan oil. And a former Tesla staffer who clashed with Elon Musk shakes up the race to run General Motors. Daniel Bach hosts.
Listen to the full interview with Cleveland Fed President Beth Hammack on WSJ’s Take On the Week.
For over 100 years, keeping Americans safe on the job has challenged the country's free-market economy. Businesses often preferred to regulate their workplaces without government oversight. But that track record is mixed. And federal efforts at safeguarding job sites at times have fallen short. Host Katherine Sullivan explores how far we've come since Frances Perkins helped put employee safety in the spotlight and what American workers still face now when they go to work.
This episode is part of The Wall Street Journal’s USA250: The Story of the World’s Greatest Economy, a collection of articles, videos and podcasts aiming to offer a deeper understanding of how America has evolved.
What did Micron’s earnings tell us about the AI boom? And what’s behind the corporate drama at Warner Bros. Discovery and Lululemon? Plus, does Medline's IPO splash bode well for future offerings? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.
What did Micron’s earnings tell us about the AI boom? And what’s behind the corporate drama at Warner Bros. Discovery and Lululemon? Plus, does Medline's IPO splash bode well for future offerings? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.
Plus: Nike stock falls after predicting declining sales. And BioMarin Pharmaceutical shares rise after announcing a new acquisition deal. Katherine Sullivan hosts.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Plus: BioMarin Pharmaceutical to acquire biotech Amicus Therapeutics for about $4.8 billion. And high-speed trading firm Jump Trading is accused of contributing to the collapse of Terraform Labs. Julie Chang hosts.
Plus: BioMarin Pharmaceutical to acquire Amicus Therapeutics for $4.8 billion. And the U.S. Navy announces a new warship for President Trump’s “Golden Fleet.” Danny Lewis hosts.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.